Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
pharmaphorum
11h
Pfizer gets a leg up in RSV as FDA clears jab for all adults
A new FDA approval has given Pfizer a broader label for its respiratory syncytial virus (RSV) vaccine Abrysvo than rival ...
clinicaladvisor.com
22h
Clesrovimab Looks Promising for RSV Prevention in Infants
Clesrovimab, formerly known as MK-1654, is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Settles civil lawsuit
NK troops in RU confirmed
Linked to E. coli outbreak
Yelp disables reviews
No abortion concessions
Trespassing charge upheld
Arlington visit records order
Veteran film producer dies
2 US troops injured in raid
Sues Biden administration
MO court upholds release
Dodgers legend dies
First father-son duo in NBA
FDA approves RSV vaccine
To close 150 locations
Lake Erie toxic algae study
DOJ alleges racial bias
Giant ‘ghost’ fish spotted
US fines American Airlines
Hashem Safieddine killed
FAA finalizes safety rules
GA election rules appeal
Gun assault trial delayed
Sex crimes trial next year
Funds corruption guilty plea
G7 Ukraine loan advances
Apple, Goldman Sachs fined
Related topics
RSV
Merck & Co.
Monoclonal antibody
Feedback